PRKAA1 and mitochondrial disease: An experimental approach that has shown promise in animal models of mitochondrial disease is the general induction of mitochondrial biogenesis, achieved for example by activating the key energy sensor and metabolic regulator, the AMP‐activated protein kinase (AMPK) [3, 4].